STEMRIM INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for STEMRIM INC..The latest application filed is for "composition for promoting growth or suppressing decrease of mesenchymal stem cells".

Company Profile

12.8.16

STEMRIM INC. - Osaka JP
STEMRIM INC. - Ibaraki-shi, Osaka JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition For Promoting Growth Or Suppressing Decrease Of Mesenchymal Stem Cells App 20220265787 - TAMAI; Katsuto ; et al.	2022-08-25
Therapeutic agent for inflammatory bowel disease Grant 11,298,403 - Tamai , et al. April 12, 2	2022-04-12
Agents For Promoting Tissue Regeneration By Recruiting Bone Marrow Mesenchymal Stem Cells And/or Pluripotent Stem Cells Into Blood App 20220047642 - TAMAI; Katsuto ; et al.	2022-02-17
Peptide Possessing Mesenchymal-Stem-Cell Mobilizing Activity App 20220009976 - TAMAI; Katsuto ; et al.	2022-01-13
Therapeutic Agent For Cartilage Disorder App 20210386823 - TAMAI; Katsuto ; et al.	2021-12-16
Method for collecting functional cells in vivo with high efficiency Grant 11,197,895 - Tamai , et al. December 14, 2	2021-12-14
Agents for promoting tissue regeneration by recruiting bone marrow mesenchymal stem cells and/or pluripotent stem cells into blood Grant 11,191,786 - Tamai , et al. December 7, 2	2021-12-07
Disease Treatment Drug Based on Mesenchymal-Stem-Cell Mobilization App 20210347839 - TAMAI; Katsuto ; et al.	2021-11-11
Peptide For Inducing Regeneration Of Tissue, And Use Thereof App 20210163552 - NIHASHI; Yoichiro ; et al.	2021-06-03
Therapeutic Agent for Psoriasis App 20210024594 - TAMAI; Katsuto ; et al.	2021-01-28
Therapeutic Agent For Inflammatory Bowel Disease App 20200384074 - TAMAI; Katsuto ; et al.	2020-12-10
Peptide For Inducing Regeneration Of Tissue And Use Thereof App 20200369736 - TAMAI; KATSUTO ; et al.	2020-11-26
Ectodermal Mesenchymal Stem Cells And Method For Producing Same App 20200291359 - TAMAI; Katsuto ; et al.	2020-09-17
Therapeutic Medicine For Fibrous Disease App 20200038486 - TAMAI; Katsuto ; et al.	2020-02-06
Peptide for inducing regeneration of tissue and use thereof Grant 10,550,165 - Tamai , et al. Fe	2020-02-04
Therapeutic Agent For Cerebral Infarction App 20190358307 - TAMAI; Katsuto ; et al.	2019-11-28
Therapeutic Agent For Cardiomyopathy, Old Myocardial Infarction And Chronic Heart Failure App 20190343924 - TAMAI; Katsuto ; et al.	2019-11-14
Peptide for inducing regeneration of tissue and use thereof Grant 10,364,276 - Tamai , et al.	2019-07-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.